ritanserin has been researched along with Kidney Neoplasms in 1 studies
Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.
Kidney Neoplasms: Tumors or cancers of the KIDNEY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kovalenko, A | 1 |
| Sanin, A | 1 |
| Kosmas, K | 1 |
| Zhang, L | 1 |
| Wang, J | 1 |
| Akl, EW | 1 |
| Giannikou, K | 1 |
| Probst, CK | 1 |
| Hougard, TR | 1 |
| Rue, RW | 1 |
| Krymskaya, VP | 1 |
| Asara, JM | 1 |
| Lam, HC | 1 |
| Kwiatkowski, DJ | 1 |
| Henske, EP | 1 |
| Filippakis, H | 1 |
1 other study available for ritanserin and Kidney Neoplasms
| Article | Year |
|---|---|
Therapeutic Targeting of DGKA-Mediated Macropinocytosis Leads to Phospholipid Reprogramming in Tuberous Sclerosis Complex.
Topics: Angiolipoma; Animals; Autophagy; Cell Proliferation; Chloroquine; Diacylglycerol Kinase; Down-Regula | 2021 |